Gyre Therapeutics (GYRE) Non Operating Income (2010 - 2026)
Gyre Therapeutics (GYRE) reported Non Operating Income of $29000.0 for Q1 2026, down 72.9% year-over-year from $107000.0 in Q1 2025, and up 101.32% quarter-over-quarter from -$2.2 million in Q4 2025.
Gyre Therapeutics (GYRE) Non Operating Income (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 17 years of Non Operating Income data on file, last reported at $29000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at $29000.0, down 72.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.6 million (up 5.44% YoY), and the FY2025 annual result was -$1.5 million, up 9.28% from the prior year.
- Non Operating Income climbed to $29000.0 in Q1 2026 per GYRE's latest filing, from -$2.2 million in the prior quarter.
- Over five years, Non Operating Income peaked at $727000.0 in Q3 2025 and troughed at -$2.2 million in Q4 2025.
- A 5-year average of -$271800.0 and a median of -$17000.0 in 2022 frame the typical range for Non Operating Income.
- On a YoY basis, Non Operating Income climbed as much as 3600.0% in 2023 and fell as far as 133200.0% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$1000.0 in 2022, then tumbled by 23600.0% to -$237000.0 in 2023, then sank by 589.45% to -$1.6 million in 2024, then sank by 34.27% to -$2.2 million in 2025, then surged by 101.32% to $29000.0 in 2026.
- Business Quant data shows GYRE's Non Operating Income at $29000.0 in Q1 2026, -$2.2 million in Q4 2025, and $727000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | 29,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,000.00 |
| Dec 31, 2025 | -2.19 Mn |
| Sep 30, 2025 | 727,000.00 |
| Jun 30, 2025 | -145,000.00 |
| Mar 31, 2025 | 107,000.00 |
| Dec 31, 2024 | -1.63 Mn |
| Sep 30, 2024 | -75,000.00 |
| Jun 30, 2024 | -72,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | -237,000.00 |
| Sep 30, 2023 | -1.33 Mn |
| Jun 30, 2023 | 629,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | -17,000.00 |
| Dec 31, 2021 | -20,000.00 |
| Sep 30, 2021 | -16,000.00 |
| Jun 30, 2021 | -25,000.00 |
| Mar 31, 2021 | -17,000.00 |
| Dec 31, 2020 | -71,000.00 |